A Standard for Hilar and Intrapulmonary Lymph Node Dissection and Pathological Examination in Early Non-Small Cell Lung Cancer.
Zhihua Zhu,Weijian Mei,Zhengbo Song,Wenjie Jiao,Qinghua Huang,Lianxin Zhu,Chaolun An,Jianguang Shi,Wenxian Wang,Guiping Yu,Pingli Sun,Yinbin Zhang,Jianfei Shen,Yong Song,Sebastien Gilbert,Kurt Ruetzler,Nestor R. Villamizar,Chunwei Xu,Jun Qian,Wang Yao,Han Yang
DOI: https://doi.org/10.21037/tlcr-21-959
2021-01-01
Translational Lung Cancer Research
Abstract:BACKGROUND:There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with early-stage T1-3N0M0 NSCLC.METHODS:This study involved 3,002 patients with T1-3N0M0 NSCLC who underwent radical lobectomy or total pneumonectomy in the thoracic departments of 11 Chinese institutions between January 1999 and October 2013. The Cox model was applied for univariate and multivariate analyses in the examination of station 10, 11 LN and station 12, 13, 14 LN. A hilar and intrapulmonary standard (HI standard) was then established based on univariate and multiple-factor analyses conducted using the Cox model.RESULTS:Among the 3,002 patients enrolled in the study, 2,609 underwent at least one examination of station 10, 11 LN (A1), while 393 did not undergo examination of station 10, 11 LN (A0). The A0 and A1 groups had 5-year survival rates of 76% and 80%, respectively (P=0.018). Further, 1,764 patients underwent at least one examination of station 12, 13, 14 LN (B1), while 1,238 patients did not (B0). The B0 and B1 groups had 5-year survival rates of 77% and 82%, respectively (P=0.008). In total, 1,269 patients attained the HI standard (C1), and 1,733 did not (C0). The C0 and C1 groups had 5-year survival rates of 77% and 83%, respectively (P<0.001).CONCLUSIONS:The HI standard can improve both the prognosis and survival rates of patients with T1-3N0M0 NSCLC. This will provide important guidance for pulmonary LN dissection and pathological examination in NSCLC cases.